Home › Funds › Foresite Capital Management V, LLC › CGON

Foresite Capital Management V, LLC position in CGON

CG ONCOLOGY INC · Health Care

Foresite Capital Management V, LLC reported holding 1,079,050 shares of CGON (CG ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$76.7M, representing 21.17% of its reported portfolio and ranking #2 among its reported holdings. Foresite Capital Management V, LLC has disclosed CGON holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.08M sh
Reported value held$76.67M
Portfolio Weight21.17%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management V, LLC's CGON position evolved

Foresite Capital Management V, LLC first disclosed a stake in CGON in Q1 2024 at 692,550 shares (US$30.4M). The position peaked in Q2 2026 at 1,079,050 shares, worth US$76.7M. Across 10 filings, Foresite Capital Management V, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 1,079,050 shares valued at US$76.7M — an increase of 75,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2024 692.55K $30.40M New
Q2 2024 692.55K $21.86M Hold
Q3 2024 692.55K $26.13M Hold
Q4 2024 692.55K $19.86M Hold
Q1 2025 859.05K $21.04M Add
Q2 2025 1.00M $26.11M Add
Q3 2025 1.00M $40.44M Hold
Q4 2025 1.00M $41.69M Hold
Q1 2026 1.00M $67.95M Hold
Q2 2026 1.08M $76.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGON and 13F data

CGON (CG ONCOLOGY INC) is a Health Care company. 52 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGON

All CGON fund holders →

FAQ

How long has Foresite Capital Management V, LLC held CGON?

Foresite Capital Management V, LLC has disclosed CGON holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Foresite Capital Management V, LLC's current position in CGON?

As of Q2 2026, Foresite Capital Management V, LLC holds 1.08M shares of CGON (CG ONCOLOGY INC), valued at $76.67M, representing 21.17% of its reported portfolio and ranking #2.

Has Foresite Capital Management V, LLC been buying or selling CGON?

In the latest 13F filing (Q2 2026), Foresite Capital Management V, LLC increased its position in CGON. The position peaked in Q2 2026 at 1.08M shares.

Which other funds hold CGON?

Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.